Skip to main content

Interaction between linezolid and Mycobacterium tuberculosis in an experimental in vitro model

Buy Article:

$51.00 plus tax (Refund Policy)


Cremades R, Rodríguez JC, Garcia-Pachón E, Galiana A, Ruiz-García M, López P, Royo G. Interaction between linezolid and Mycobacterium tuberculosis in an experimental in vitro model. APMIS 2011; 119: 304–8.

As linezolid is emerging as a useful alternative in the treatment of multi-resistant tuberculosis, we developed an in vitro model to elucidate certain aspects of the interaction that takes place between the microorganism and the antibiotic. We found that the drug does not generate resistant mutants following repeated exposure at subinhibitory concentrations and that it exhibits bactericidal activity against most of the susceptible strains in vitro at high concentrations (83.3% of the strains at concentrations of 50 μg/mL) in the exponential growth phase. This bactericidal activity is much less if the microorganism is in nonreplicating phase, even in the case of susceptible strains in vitro. Therefore, linezolid appears to be an alternative as far as generation of resistance is concerned in the treatment of multi-resistant tuberculosis. However, it has limited bactericidal capacity against strains in nonreplicant phase, which makes it necessary to use linezolid in combination with other drugs that act on these microorganisms.

Keywords: Linezolid; Mycobacterium tuberculosis; bactericidal activity; multi-resistant tuberculosis; mutants

Document Type: Research Article


Publication date: April 1, 2011

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more